CORDIS Project

Genetic prostate cancer variants as biomarkers of disease progression

PROMARK·202059·FP7

Funding breakdown and partner intelligence are Premium

Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1

Upgrade

Start free • Cancel anytime • 14-day refund guarantee

View on CORDIS

Funding data

Programme: FP7
Participants: 4
Start - End: 01/01/2008 — 31/12/2012
Status: CLOSED

Summary

This project investigates genetic markers to improve prostate cancer prognosis. By analyzing DNA from over 8,000 patients, it aims to identify inherited variants that indicate disease severity and progression, ultimately leading to a more accurate prognostic test for localized prostate cancer.

Objective

Prostate cancer is the most common cancer in males in Europe, causing over 87,000 deaths in 2006.

Early diagnosis and treatment are key factors in determining survival but screening methods based on the commonly-used PSA blood test have low specificity and result in excessive treatment of localized lesions that might never progress to symptomatic cancer.

Biomarkers that help determine which of the early stage tumors will remain confined to the prostate and which will progress to an invasive, agg…

Full objective and premium intelligence

Upgrade to Premium for the complete objective, AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Coordinator

DECODE GENETICS EHF

ISLENSK ERFDAGREINING EHF

Country: Iceland, Reykjavik
Organization type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No

Network and participants(4 participants)

Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom, Cambridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
UNIVERSITY COLLEGE LONDON
LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
STICHTING RADBOUD UNIVERSITEIT
Netherlands, Nijmegen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
PHIB
Romania, BUCURESTI
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
participant

4 participants shown of 6

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Partner & research intelligence

Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.

Consortium analytics and research context are Premium

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

CORDIS call / funding scheme

Call: —
Sub call: FP7-HEALTH-2007-A
Funding scheme: CP-FP - Small or medium-scale focused research project
Domain note: This block describes the CORDIS project call context. Live open opportunities are managed in the Funding & Tenders domain.

Fields of Science (EuroSciVoc)

Guests see up to 5 EuroSciVoc fields.

Engineering and technologyMedical engineeringMedical laboratory technologyLaboratory samples analysis

Topic

Guests see up to 5 topics.

HEALTH-2007-2.4.1-2

Sector

Guests see up to 5 sectors.

Health & Biotech